Hypersensitivity in the lungs is responsible for acute respiratory failure in COVID‐19 patients: Case series of patients who received high‐dose/short‐term methylprednisolone

Hypersensitivity in the lungs is responsible for acute respiratory failure in COVID‐19 patients: Case series of patients who received high‐dose/short‐term methylprednisolone

Abstract Background COVID‐19 is a highly contagious respiratory disease caused by the SARS‐CoV‐2 virus. Patients with severe disease have a high fatality rate and face a huge medical burden due to the need for invasive mechanical ventilation. Hypoxic respiratory failure is the major cause of death i...

Full description

Bibliographic Details
Main Authors: Meizhu Chen, Changli Tu, Cuiyan Tan, Xiaobin Zheng, Fengfei Sun, Yingjian Liang, Honglei Shi, Jian Wu, Yiying Huang, Zhenguo Wang, Kongqiu Wang, Minmin Lin, Weiming Wu, Hong Zhou, Jing Liu, Jin Huang
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Clinical and Translational Allergy
Subjects:
anti‐SARS‐CoV‐2 specific IgE
COVID‐19
hypersensitivity
hypoxic respiratory failure
methylprednisolone
Online Access:https://doi.org/10.1002/clt2.12056

Internet

https://doi.org/10.1002/clt2.12056

Similar Items